Skip to content

Comparing Two Different Emotion Therapies for Autistic Youth and Young Adults

The Emotion Awareness and Skills Enhancement (EASE) Program Versus the Unified Protocol (UP)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06158581
Enrollment
470
Registered
2023-12-06
Start date
2024-04-08
Completion date
2027-08-01
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Brief summary

Too few clinicians are able and willing to help autistic patients. A recent review identified challenges to mental health service delivery in autism, including a lack of interventions designed for community implementation and limited workforce capacity. It has been argued that improving impairment in emotion regulation has the potential to improve a range of mental health difficulties in autistic people. In this clinical trial, the investigators are comparing two evidence-based interventions for emotion regulation, to determine if one created specifically for autistic people is clinically superior. The interventions will be implemented in the community, through partnering agencies.

Detailed description

This study will compare the effectiveness of two transdiagnostic interventions for autistic adolescents and young adults - an intervention in widespread use among non-autistic populations (The Unified Protocol; UP) versus an autism-specific intervention (The Emotion Awareness and Skills Enhancement Program; EASE). The UP and EASE are ideal comparators because they are structurally equivalent and transdiagnostic - both shown to improve mental health outcomes that stakeholders identify as important, such as depression, irritability, and anxiety. The investigators will partner with 12 different community clinics in Pennsylvania and Alabama to recruit participants and facilitate the interventions. Each clinic will be randomized to use either UP or EASE. The investigators will look at effectiveness of the treatments, as well as the feasibility, benefits and harms.

Interventions

BEHAVIORALThe Emotion Awareness and Skills Enhancement Program

EASE is a cutting-edge program created by researchers at the University of Alabama and the University of Pittsburgh in collaboration with autistic individuals, caregivers of autistic youth, and therapists. The overarching goal of the program is to support autistic clients who want to work on emotion regulation. EASE is unique because it targets emotional distress in autistic youth and adults, instead of targeting the core symptoms of autism (i.e., it is not a social skills intervention). The program is a 16-session, mindfulness-based intervention. Each session is 1:1 for 45 minutes to one hour. While the program is designed for individual intervention, caregivers are also invited to play an active role on the care team.

BEHAVIORALThe Unified Protocol

UP is a thoroughly-studied, manualized intervention created by researchers at the University of Miami in conjunction with researchers at Boston University. The program was designed to be customizable to meet the needs of people with a variety of diagnoses, allowing more individuals to access emotion regulation resources. The protocol also has different modules to accommodate different developmental levels (UP-Children, UP-Adolescent, UP-Adult). The overall goal of UP is to help clients identify emotions and build new strategies to cope with stressful life situations and distressing emotions. The protocol is flexible, with each session is about 45 to 60 minutes and the number of sessions varying between 12 - 21 sessions. For the current study, the treatment will take place over 16 sessions. The intervention is cognitive behavioral therapy (CBT) based but also includes hints of mindfulness-based intervention strategies.

Sponsors

University of Pittsburgh
Lead SponsorOTHER
University of Alabama, Tuscaloosa
CollaboratorOTHER
Patient-Centered Outcomes Research Institute
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

A rater blind to condition assignment will assign CGI ratings.

Eligibility

Sex/Gender
ALL
Age
10 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

* professional diagnosis of ASD * a score in the clinical range on the EDI-Reactivity or EDI-Dysphoria scale based on caregiver report or self-report * The study is open to people with a range of communication abilities. Participants must be able to consent to the study themselves and answer questions about themselves. * Participants need to have a support person that could answer questions about them too. This could be a parent, caregiver, family member, partner or friend. Independent adults can opt out of this portion. * Participants must live in Alabama or Pennsylvania.

Exclusion criteria

\- Higher level of care is needed (Imminent Suicide / Homicide Threat, acute psychosis, mania)

Design outcomes

Primary

MeasureTime frameDescription
Emotion Dysregulation InventoryBaseline, Midpoint (after completing 8 sessions), Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatmentThe EDI does not have a single overall score. It is comprised of two scales: Reactivity and Dysphoria. Items are on a 0 to 4 scale, where 0 is Never happens and 4 is Almost always happens or causes a serious problem. There are clinical cutoffs for both scales.
Weiner's Acceptability, Appropriateness, & Feasibility of Intervention ScalesBaseline and Post treatment of first client (after all 16 sessions, average 16-20 weeks)Weiner's is a widely used 12-item battery of three scales assessing intervention acceptability, appropriateness, and feasibility with strong psychometric properties. There is a 1 to 5 scale, where 1 is Completely disagree and 5 is Completely agree. Higher scores indicate greater acceptability, appropriateness, and feasibility.
Provider Self-Efficacy ScaleBaseline and Post trial (4 years)It assesses both knowledge (of protocol) and confidence (in one's ability to implement as intended). It is a 0-10 scale, where 0 is not at all confident and 10 is extremely confident. Higher scores indicate higher confidence.

Secondary

MeasureTime frameDescription
Clinical Global ImpressionsBaseline, Post treatment (after all 16 sessions, average 16-20 weeks)The CGI will be used as a measure of overall improvement. The CGI was designed to measure overall symptomatic change at a specific time as compared to baseline that is completed by a rater who is blind to treatment assignment. Scores range from 1 (Very Much Improved) to 4 (Unchanged) to 7 (Very Much Worse). It is only a single item, and lower scores indicate more improvement.
PROMIS DepressionBaseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatmentIt is a brief, change sensitive 8 item measure. It is a 1-5 scale, where 1 is Never and 5 is Always.
PROMIS AnxietyBaseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatmentIt is a brief, change sensitive 8 item measure. It is a 1-5 scale, where 1 is Never and 5 is Always.
Buss-Perry Aggression QuestionnaireBaseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatment27-item self-report measure of general aggression, physical aggression, verbal aggression, anger, and hostility. It is a 1-7 scale, where 1 is Extremely uncharacteristic of me and 7 is Extremely characteristic of me.
Emotion Regulation Questionnaire for Children and AdolescentsBaseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatmentERQ-CA has10 items that comprise of two scales: cognitive reappraisal use and expressive suppression, which are two regulatory strategies considered adaptive and protective in terms of mental health. It is a 1-7 scale, where 1 is Strongly disagree and 7 is Strongly agree.
Child & Adolescent Mindfulness MeasureBaseline, Midpoint (after completing 8 sessions), Post treatment (after all 16 sessions, average 16-20 weeks)CAMM is a 10-item self-report measure of mindfulness. It is a 0-4 scale, where 0 is Never true and 4 is Always true. When scoring, you reverse all scores (i.e. 0 to 4) and then sum. Higher scores correspond to higher levels of mindfulness.
WHO Quality of Life-BREF-IDBaseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatmentWHOQoL-BREF-ID is a simplified version of the World Health Organization Quality of Life. It has a 3 or 5 point visual response scale, where 1 is Not at all and 5 is Totally.
Satisfaction with Life ScaleBaseline, Post treatment (after all 16 sessions, average 16-20 weeks)Satisfaction was Life Scale is a 5-item measure of global life satisfaction. It is a 1-7 scale, where 1 is Strongly disagree and 7 is Strongly agree.
Self-Compassion Scale-Youth VersionBaseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatmentSelf-Compassion Scale - Youth Version consists of 17 self-report items ranked on a 5-point Likert scale, yielding six subscales (self-kindness, self-judgment, common humanity, isolation, mindfulness, over-identification) and an overall score. 1 is Almost Never and 5 Almost Always.
Relationships, Employment, Autonomy, and Life SatisfactionBaseline, Post treatment (after all 16 sessions, average 16-20 weeks)REALS Measures are a compilation of scales tapping many areas of adult life. Each scale is scored independently and should be utilized as different sources of information. It does not produce a global outcome score. With the frequency scales, it is a 0-4 scale where 0 is Never and 4 is Always.
AASPIRE Flourishing ScaleBaseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatmentIt is 9 item scale that assesses aspects of life satisfaction for autistic individuals. It is a scale from strongly disagree to strongly agree.
AASPIRE Burnout Scale Short FormBaseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatmentIt is a 14-item self-report measure of autistic burnout. It is a scale from strongly disagree to strongly agree.
Credibility and Expectancy QuestionnaireBaseline, Post treatment (after all 16 sessions, average 16-20 weeks)It will assess treatment expectancy and rationale for the assessed treatments.
AASPIRE Patient Health Questionnaire-9Baseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatmentThis is a 9-item self-report questionnaire for screening, diagnosing, monitoring and measuring the severity of depression, that includes an item that is widely utilized as an index of suicidal ideation severity. Each item is rated on a scale from Rarely or not at all to Almost every day. Higher scores would relate to higher depression.
Inventory of Statements about Self-InjuryBaseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatmentISAS is a continuous self-report measure of self-injurious behaviors. It is the most commonly used measure of self-injury. Higher numbers in Section 1 would indicate more self-injurious behaviors.
Working Alliance InventoryMidpoint (after completing 8 sessions, average 8 weeks), After completing 15 sessions (average 15-19 weeks)WAI is a clinician-report measure assessing the therapeutic alliance between the client/participant and the clinician. The measure is 12 items, rated on a 5-point scale.
Vanderbilt Therapeutic Alliance Scales Revised, Short Form2 randomized timepoints over up to 20 WeeksVTAS-R-SF is an observational measure of alliance and consists of five items to capture the strength of the perceived support and trust, participation, and agreement on tasks and goals between client and therapist. Each item is rated 0-5, and higher scores mean more alliance. The measure is used for coding videos or audio files of the therapy sessions. It will be completed twice with each participant but the timepoint is randomized (one randomized session from the first half of therapy and one randomized session from the second half of therapy).
Child Involvement Rating Scale2 randomized timepoints over up to 20 WeeksChild Involvement Rating Scale is a 10-item, 6-point observational scale to rate involvement and engagement during therapy. The first 6 items rate positive involvement where 0 is not at all and 5 is a great deal. The last 4 items rate negative involvement where 0 is not at all and 5 is a great deal. The measure is used for coding videos or audio files of the therapy sessions. The measure will be completed twice with each participant but the timepoint is randomized (one randomized session from the first half of therapy and one randomized session from the second half of therapy).

Countries

United States

Contacts

CONTACTKara Duman, MSW
emotiontherapy@upmc.edu1-866-647-3436
CONTACTMadison Bradley
emotiontherapy@ua.edu205-348-2472
PRINCIPAL_INVESTIGATORCarla Mazefsky, PhD

University of Pittsburgh

PRINCIPAL_INVESTIGATORSusan White, PhD

University of Alabama at Birmingham

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026